1. Targeting YAP/TAZ mechanosignaling to ameliorate stiffness-induced Schlemm’s canal cell pathobiology
   Haiyan Li et al, 2024, American Journal of Physiology-Cell Physiology CrossRef
2. RhoA Activation Decreases Phagocytosis of Trabecular Meshwork Cells
   Tomokazu Fujimoto et al, 2021, Current Eye Research CrossRef
3. Dexamethasone Downregulates Autophagy through Accelerated Turn-Over of the Ulk-1 Complex in a Trabecular Meshwork Cells Strain: Insights on Steroid-Induced Glaucoma Pathogenesis
   Diego Sbardella et al, 2021, International Journal of Molecular Sciences CrossRef
4. RhoA/ROCK-YAP/TAZ Axis Regulates the Fibrotic Activity in Dexamethasone-Treated Human Trabecular Meshwork Cells
   Zhicheng Liu et al, 2021, Frontiers in Molecular Biosciences CrossRef
5. YAP/TAZ Promote Fibrotic Activity in Human Trabecular Meshwork Cells by Sensing Cytoskeleton Structure Alternation
   Shan Huang et al, 2022, Chemosensors CrossRef
6. Simvastatin Attenuates Glucocorticoid-Induced Human Trabecular Meshwork Cell Dysfunction via YAP/TAZ Inactivation
   Hannah Yoo et al, 2023, Current Eye Research CrossRef
7. The Hippo signalling pathway and its impact on eye diseases
   Yuxiang Du, 2024, Journal of Cellular and Molecular Medicine CrossRef
8. Glucocorticoids Preferentially Influence Expression of Nucleoskeletal Actin Network and Cell Adhesive Proteins in Human Trabecular Meshwork Cells
   William Bachman et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
9. Extracellular Matrix Stiffness and TGFβ2 Regulate YAP/TAZ Activity in Human Trabecular Meshwork Cells
   Haiyan Li et al, 2022, Frontiers in Cell and Developmental Biology CrossRef